• Kymera Therapeutics' (KYMR) "Outperform" Rating Reiterated at Leerink Partners

    Источник: Buzz FX / 27 дек 2024 07:46:12   America/Chicago


    Kymera Therapeutics' (KYMR) "Outperform" Rating Reiterated at Leerink Partners Written by MarketBeat December 27, 2024 Share Link copied to clipboard. Kymera Therapeutics ( NASDAQ:KYMR - Get Free Report ) 's stock had its "outperform" ratin
    Read more...
Опубликовать